Prostate cancer decisions — 2024

The Veteran's TDIU and SMC under the provisions of 38 U.S.C. § 1114(s) are granted due to his service-connected disabilities, including residuals of prostate cancer with urinary incontinence, other specified trauma (PTSD), Parkinsonism, and hyperthyroidism.

The Board has denied the Veteran's claims for service connection for various conditions, including asthma, chronic bronchitis, tonsilitis, emphysema, COPD, gastritis, granulomatous disease, leukemia, Parkinson's disease, prostate cancer, respiratory cancer, and multiple myeloma. The reasons provided include a lack of evidence supporting the presence of these conditions during or approximate to the pendency of the claims.

The Veteran's appeal for restoration of a 100% rating for prostate cancer from February 1, 2010 to February 3, 2017 was dismissed because no VA Form 9 was submitted following the issuance of the August 2010 Statement of the Case.

The Veteran's prostate cancer is related to his in-service asbestos exposure, and the Board has granted service connection for this condition.

The Board has granted earlier effective dates of September 25, 2019 for the grant of service connection for prostate cancer and erectile dysfunction (ED), as well as basic eligibility to Dependents' Educational Assistance (DEA). The Veteran's claim was initially denied in February 2020 but was later reconsidered due to a request for higher-level review filed during the COVID-19 pandemic.,The Board also granted special monthly compensation (SMC) based on loss of use of a creative organ, as this decision is granting an earlier effective date of September 25, 2019.

The Veteran's prostate cancer, which was diagnosed and treated during service, is now granted as service connected due to its relation to chronic prostatitis. The hypertension claim has been remanded for further review.

The Veteran's initial 20% disability rating for prostate cancer residuals, including awakening to void three times per night, is granted effective October 22, 2021. The effective date of service connection for erectile dysfunction is also set at October 22, 2021.

Service connection for diabetes mellitus type II and prostate cancer is granted. Service connection for heart condition is remanded due to insufficient evidence.

The Board has remanded the case due to insufficient information regarding the Veteran's exposure to herbicide agents, specifically Agent Orange. The AOJ is instructed to attempt to verify the Veteran's claimed in-service exposure and consider the term 'defoliants' on ship manifests.

New evidence has been submitted that may support the Veteran's claims for service connection. The AOJ will review these new claims and determine if they meet the criteria for service connection.

The Veteran's claim for service connection for prostate cancer, including as due to herbicide exposure, is being remanded for further review. New evidence submitted by the Veteran suggests he was within 12 nautical miles of Vietnam during his service on the USS Constellation.

The Board has determined that the Veteran is unable to self-sustain in the community due to his dementia and other medical conditions, granting a Level 2 stipend in the PCAFC program.

The Veteran's prostate cancer is granted service connection on a direct basis, with an effective date of May 5, 2022. The condition was not previously service-connected and the claim was filed after the applicable statute of limitations.

The Veteran's bilateral hearing loss and tinnitus are granted as service-connected.,Service connection is also granted for hypothyroidism, prostate cancer, and diabetes mellitus type II due to in-service herbicide exposure. Ischemic heart disease remains denied.

The Veteran's appeals for ratings related to prostate cancer residuals and a front torso scar have been dismissed due to his death.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of a direct causal relationship between his in-service exposure to jet fuel and his current diagnosis of prostate cancer.

The Veteran's prostate cancer is related to his in-service exposure to burn pits, and the Board has granted service connection for this condition.

The Board has granted service connection for bilateral hearing loss and tinnitus, but has remanded the claims for prostate cancer, incontinence, and seizure disorder due to insufficient evidence.

The Board has determined that the Veteran's prostate cancer may be related to exposure to contaminated water at Camp Lejeune during service, and thus remands for a VA examination to determine this relationship.

The Veteran's prostate cancer and erectile dysfunction are granted service connection, with the prostate cancer being presumed due to herbicide exposure in Thailand. The erectile dysfunction is secondary to the service-connected prostate cancer.